BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/30/2015 5:58:00 PM | Browse: 991 | Download: 1156
Publication Name World Journal of Virology
Manuscript ID 14767
Country/Territory United States
Received
2014-10-23 08:37
Peer-Review Started
2014-10-23 18:00
To Make the First Decision
2014-11-14 17:40
Return for Revision
2014-11-17 18:59
Revised
2014-12-04 00:10
Second Decision
2015-02-04 11:53
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2015-02-11 16:19
Articles in Press
2015-02-11 16:19
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2015-04-17 17:26
Publish the Manuscript Online
2015-04-30 17:58
ISSN 2220-3249 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Infectious Diseases
Manuscript Type Minireviews
Article Title Debunking the myths perpetuating low implementation of isoniazid preventive therapy amongst human immunodeficiency virus-infected persons
Manuscript Source Invited Manuscript
All Author List Christopher Akolo, Florence Bada, Evaezi Okpokoro, Ogochukwu Nwanne, Sharon Iziduh, Eno Usoroh, Taofeekat Ali, Vivian Ibeziako, Olanrewaju Oladimeji and Michael Odo
Funding Agency and Grant Number
Corresponding Author Christopher Akolo, MBBS, MSc, FWACP, Senior Technical Advisor HIV/TB, Population Services International, 1120 19th Street, N.W. Ste. 600, Washington, DC 20036, United States. akolochris@yahoo.com
Key Words Human immunodeficiency virus; Isoniazid preventive therapy; Tuberculosis; Chemoprophylaxis
Core Tip To better inform healthcare providers, policy makers and human immunodeficiency virus-infected persons about isoniazid preventive therapy (IPT), this article summarizes the existing evidence in support of IPT including recommendations for scale-up of implementation globally.
Publish Date 2015-04-30 17:58
Citation Akolo C, Bada F, Okpokoro E, Nwanne O, Iziduh S, Usoroh E, Ali T, Ibeziako V, Oladimeji O, Odo M. Debunking the myths perpetuating low implementation of isoniazid preventive therapy amongst human immunodeficiency virus-infected persons. World J Virol 2015; 4(2): 105-112
URL http://www.wjgnet.com/2220-3249/full/v4/i2/105.htm
DOI http://dx.doi.org/10.5501/wjv.v4.i2.105
Full Article (PDF) WJV-4-105.pdf
Full Article (Word) WJV-4-105.doc
Manuscript File 14767-Review.docx
Answering Reviewers 14767-Answering reviewers.pdf
Conflict-of-Interest Disclosure Form 14767-Conflict-of-interest statement.pdf
Copyright License Agreement 14767-Copyright assignment.pdf
Peer-review Report 14767-Peer-review(s).pdf
Scientific Misconduct Check 14767-Scientific misconduct check.pdf
Scientific Editor Work List 14767-Scientific editor work list.pdf